AcquisitionOther

Ligand Pharmaceuticals Incorporated acquired XOMA Royalty Corporation

Name: Ligand Pharmaceuticals Incorporated -> XOMA Royalty Corporation
Start: 2026-07-14

Public M&A record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

Ligand Pharmaceuticals Incorporated -> XOMA Royalty Corporation · $739 million

Build diversified portfolio of high-value royalty assets and expand exposure to commercial and development-stage assets.